Artificial Intelligence (AI) in Precision Medicine Market Size, Share, and Trends 2024 to 2034

The global artificial intelligence (AI) in precision medicine market size is calculated at USD 3.15 billion in 2025 and is forecasted to reach around USD 49.49 billion by 2034, accelerating at a CAGR of 35.80% from 2025 to 2034. The North America artificial intelligence (AI) in precision medicine market size surpassed USD 700 million in 2024 and is expanding at a CAGR of 35.94% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the

  • Last Updated : January 2025
  • Report Code : 2696
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) in Precision Medicine Market 

5.1. COVID-19 Landscape: Artificial Intelligence (AI) in Precision Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Artificial Intelligence (AI) in Precision Medicine Market, By Technology

8.1. Artificial Intelligence (AI) in Precision Medicine Market, by Technology

8.1.1 Machine Learning

8.1.1.1. Market Revenue and Forecast

8.1.2. Querying Method

8.1.2.1. Market Revenue and Forecast

8.1.3. Deep Learning

8.1.3.1. Market Revenue and Forecast

8.1.4. Deep Learning

8.1.4.1. Market Revenue and Forecast

8.1.5. Context-Aware Processing

8.1.5.1. Market Revenue and Forecast

8.1.6. Natural Language Processing

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Artificial Intelligence (AI) in Precision Medicine Market, By Component

9.1. Artificial Intelligence (AI) in Precision Medicine Market, by Component

9.1.1. Hardware

9.1.1.1. Market Revenue and Forecast

9.1.2. Software

9.1.2.1. Market Revenue and Forecast

9.1.3. Service

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Artificial Intelligence (AI) in Precision Medicine Market, By Therapeutic Application 

10.1. Artificial Intelligence (AI) in Precision Medicine Market, by Therapeutic Application

10.1.1. Oncology

10.1.1.1. Market Revenue and Forecast

10.1.2. Neurology

10.1.2.1. Market Revenue and Forecast

10.1.3. Cardiology

10.1.3.1. Market Revenue and Forecast

10.1.4. Respiratory

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Artificial Intelligence (AI) in Precision Medicine Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Technology

11.1.2. Market Revenue and Forecast, by Component

11.1.3. Market Revenue and Forecast, by Therapeutic Application

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Technology

11.1.4.2. Market Revenue and Forecast, by Component

11.1.4.3. Market Revenue and Forecast, by Therapeutic Application

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Technology

11.1.5.2. Market Revenue and Forecast, by Component

11.1.5.3. Market Revenue and Forecast, by Therapeutic Application

11.2. Europe

11.2.1. Market Revenue and Forecast, by Technology

11.2.2. Market Revenue and Forecast, by Component

11.2.3. Market Revenue and Forecast, by Therapeutic Application

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Technology

11.2.4.2. Market Revenue and Forecast, by Component

11.2.4.3. Market Revenue and Forecast, by Therapeutic Application

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Technology

11.2.5.2. Market Revenue and Forecast, by Component

11.2.5.3. Market Revenue and Forecast, by Therapeutic Application

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Technology

11.2.6.2. Market Revenue and Forecast, by Component

11.2.6.3. Market Revenue and Forecast, by Therapeutic Application

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Technology

11.2.7.2. Market Revenue and Forecast, by Component

11.2.7.3. Market Revenue and Forecast, by Therapeutic Application

11.3. APAC

11.3.1. Market Revenue and Forecast, by Technology

11.3.2. Market Revenue and Forecast, by Component

11.3.3. Market Revenue and Forecast, by Therapeutic Application

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Technology

11.3.4.2. Market Revenue and Forecast, by Component

11.3.4.3. Market Revenue and Forecast, by Therapeutic Application

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Technology

11.3.5.2. Market Revenue and Forecast, by Component

11.3.5.3. Market Revenue and Forecast, by Therapeutic Application

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Technology

11.3.6.2. Market Revenue and Forecast, by Component

11.3.6.3. Market Revenue and Forecast, by Therapeutic Application

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Technology

11.3.7.2. Market Revenue and Forecast, by Component

11.3.7.3. Market Revenue and Forecast, by Therapeutic Application

11.4. MEA

11.4.1. Market Revenue and Forecast, by Technology

11.4.2. Market Revenue and Forecast, by Component

11.4.3. Market Revenue and Forecast, by Therapeutic Application

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Technology

11.4.4.2. Market Revenue and Forecast, by Component

11.4.4.3. Market Revenue and Forecast, by Therapeutic Application

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Technology

11.4.5.2. Market Revenue and Forecast, by Component

11.4.5.3. Market Revenue and Forecast, by Therapeutic Application

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Technology

11.4.6.2. Market Revenue and Forecast, by Component

11.4.6.3. Market Revenue and Forecast, by Therapeutic Application

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Technology

11.4.7.2. Market Revenue and Forecast, by Component

11.4.7.3. Market Revenue and Forecast, by Therapeutic Application

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Technology

11.5.2. Market Revenue and Forecast, by Component

11.5.3. Market Revenue and Forecast, by Therapeutic Application

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Technology

11.5.4.2. Market Revenue and Forecast, by Component

11.5.4.3. Market Revenue and Forecast, by Therapeutic Application

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Technology

11.5.5.2. Market Revenue and Forecast, by Component

11.5.5.3. Market Revenue and Forecast, by Therapeutic Application

Chapter 12. Company Profiles

12.1. Novo Nordisk A/S

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. GE Healthcare

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Intel Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. NVIDIA Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Microsoft Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Alphabet Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. IBM Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. BioXcel Therapeutics Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Enlitic Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. AstraZeneca

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global artificial intelligence (AI) in precision medicine market size was accounted at USD 3.15 billion in 2024 and it is expected to reach around USD 49.49 billion by 2034.

The global artificial intelligence (AI) in precision medicine market is poised to grow at a CAGR of 35.80% from 2025 to 2034.

The major players operating in the artificial intelligence (AI) in precision medicine market are Novo Nordisk A/S, GE Healthcare, Intel Corporation, NVIDIA Corporation, Microsoft Corporation, Alphabet Inc., IBM Corporation, BioXcel Therapeutics Inc., Enlitic Inc., AstraZeneca, Sanofi, Zephyr AI, Sensely Inc., Tempus, Berg LLC, Insilico Medicine, Modernizing Medicine Inc., Atomwise Inc and Others.

The driving factors of the artificial intelligence (AI) in precision medicine market are the increasing prevalence of cancer, the ever-increasing need and demand for tailored medications, and increasing R&D spending globally.

North America region will lead the global artificial intelligence (AI) in precision medicine market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client